S100A4 Orchestrates Fibroblast Fate to Drive Fibrotic Remodeling
The FASEB Journal · 30.06.2026 · 40 (12)
DOI: 10.1096/fj.202600886r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 13.06.2026. Verfasst von Spring Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Translational Biomedicine, Department of Anesthesiology & Perioperative Medicine, Heersink School of Medicine, University o…. Hauptthemen laut MEDLINE: S100 Calcium-Binding Protein A4, Fibroblasts, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute on Aging (NIA), U.S. Department of Veterans Affairs (VA), NHLBI NIH HHS.
Abstract (Originalsprache)
Fibroblast survival and dysregulated activation drive fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). During physiological wound repair, fibroblasts are transiently activated to restore tissue integrity and are subsequently cleared by programmed cell death. In fibrotic disease, however, fibroblasts evade apoptosis and persist in a pathologically activated state. Although S100A4 has been implicated in fibrotic lung disease, the mechanisms by which S100A4 governs fibroblast fate and sustains profibrotic behavior remain unclear. Here, we identify S100A4 as a key regulator of apoptosis‐resistant, profibrotically activated fibroblasts through engagement of extracellular signal‐regulated kinase (ERK) signaling. In primary murine lung fibroblasts, S100A4 activates ERK, resulting in a coordinated program of fibroblast activation, including increased migration, extracellular matrix (ECM) contractility, stress fiber formation, and alpha‐smooth muscle actin (α‐SMA) induction. Functionally, S100A4 confers resistance to apoptosis induced by pro‐apoptotic and oxidative stress stimuli, as evidenced by reduced cleaved caspase‐3 and preserved cell viability. Pharmacological blockade of ERK signaling attenuates these responses, supporting ERK as an important downstream mediator of S100A4‐driven fibroblast activation and survival programs. Extending these findings to disease‐relevant contexts, bleomycin (BLM)‐induced lung injury in mice induces robust fibrotic remodeling, excessive collagen deposition, and transcriptional upregulation of S100A4. Consistently, primary lung fibroblasts from IPF patients exhibit elevated S100A4 expression, enhanced ERK activation, and increased α‐SMA expression, demonstrating conservation of this signaling axis across experimental models and human disease. Importantly, siRNA‐mediated knockdown of S100A4 in IPF fibroblasts suppresses ERK activation and attenuates expression of key profibrotic genes, indicating that S100A4 contributes to maintaining the fibrotic program in IPF fibroblasts. Collectively, these findings define a mechanistic link between S100A4‐mediated fibroblast survival and activation that drives pathological matrix remodeling and identify S100A4 and ERK as potential therapeutic targets in pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular and Translational Biomedicine, Department of Anesthesiology & Perioperative Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Section of Pulmonary Diseases, Critical Care and Environmental Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
- Birmingham Veterans Affairs Health Care System, Birmingham, Alabama, USA.
ORCID-Profile: Spring Li, Brant M Wagener, Qiang Ding
Förderung
- HHS | NIH | National Institute on Aging (NIA)
- U.S. Department of Veterans Affairs (VA)
- NHLBI NIH HHS
- NIA NIH HHS
- BLRD VA
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Li, S., Cai, B., Zhang, X., Cai, G., Zhou, Y., Wagener, B. M., & Ding, Q. (2026). S100A4 Orchestrates Fibroblast Fate to Drive Fibrotic Remodeling. The FASEB Journal, 40(12). https://doi.org/10.1096/fj.202600886r
Vancouver
Li S, Cai B, Zhang X, Cai G, Zhou Y, Wagener BM, et al. S100A4 Orchestrates Fibroblast Fate to Drive Fibrotic Remodeling. The FASEB Journal. 2026;40(12). doi:10.1096/fj.202600886r
BibTeX
@article{Li2026,
author = {Li, Spring and Cai, Banruo and Zhang, Xu and Cai, Guoqiang and Zhou, Yong and Wagener, Brant M and Ding, Qiang},
title = {S100A4 Orchestrates Fibroblast Fate to Drive Fibrotic Remodeling},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {12},
doi = {10.1096/fj.202600886r}
}
EUVIMED